Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SANTHERA-PHARMACEUTICALS--195471/news/Santhera-Announces-Full-Enrollment-of-ReveraGen-s-Pivotal-VISION-DMD-Study-with-Vamorolone-in-Duch-31271538/?utm_source=whatsapp&utm_medium=social&utm_campaign=share